SLP Simulations Plus: Rasio nilai perusahaan marang pendapatan

Simulations Plus (SLP) - logo korporat

Geopolitical fragmentation is driving the search for autonomous IT tools for drug development, despite sanction restrictions. The cloud-based biomodeling environment of Simulations Plus, Inc. (SLP) is deeply integrated into R&D processes, creating strong customer dependency. High FDA standards make switching software critically risky for pharma behemoths. The Enterprise Value to Sales ratio demonstrates the business valuation dynamics, where the 3955.28 level serves as a key benchmark.

SLP Simulations Plus Inc.: Nilai perusahaan marang pendapatan ing interval 23.11.2025 - 18.10.2026

SLP (Simulations Plus Corp): rincian analitis lan laporan miturut indikator

- rega lan prakiraan konsensus rega:
Pambiji fundamental:SLP - simulations-plus.com
Produk merek Simulations Plus Inc

This indicator compares the total enterprise value of the business with its annual revenue, excluding the impact of leverage. By analyzing the EV/Revenue multiple, an investor determines the fair value of assets during periods of market volatility. A downward trend on this chart signals undervaluation, although it requires a verification of the issuer's solvency. For Simulations Plus, Inc. (SLP), the absence of debt makes this metric exceptionally transparent. The high margins of biosimulation software confirm the fundamental stability of the business.

Analisis pesaing

Multiplikator nilai perusahaan marang pendapatan veeva.com|DOCS (Doximity) - Nilai perusahaan marang pendapatan|HQY - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Waystar Inc.|CRVL: Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Privia Health Group (PRVA)|Multiplikator EV/Sales huronconsultinggroup.com (HURN)|Certara Inc - Nilai perusahaan marang pendapatan|OMCL - Nilai perusahaan marang pendapatan|GDRX - Rasio nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan Schrodinger Corp SDGR|PHR: Multiplikator EV/Sales|OMDA - Rasio total nilai perusahaan marang pendapatan|EVH (Evolent Health Inc) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan HSTM (HealthStream)|Multiplikator EV/Sales DH|CCSI (Consensus Corp) - Nilai bisnis marang pendapatan|agilon health Inc - Nilai perusahaan marang pendapatan|absci.com - Rasio nilai perusahaan marang pendapatan|SY - Rasio nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan NRC (National Research)|USA Mobility (SPOK) - Rasio nilai perusahaan marang pendapatan|OPRX: Koefisien nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan TBRG|Multiplikator nilai perusahaan marang pendapatan sophiagenetics.com SOPH|Multiplikator EV/Sales HCAT|CCLD (CareCloud Inc.) - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Research Solutions Inc. RSSS|DLHC - Nilai perusahaan marang pendapatan|ONMD - Rasio nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan Scienture Holdings Inc SCNX|HCTI: Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan ISPC|BFRG (Bullfrog AI) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan SCWorx Inc (WORX)|Multiplikator EV/Sales MSPR|ICCT - Multiplikator nilai perusahaan marang pendapatan|Multiplikator EV/Sales MEDS (TRxADE Health Corp)|Rasio nilai perusahaan marang dodolan Orgenesis|R1 RCM - Multiplikator EV/Sales|Nilai bisnis marang pendapatan SHCR (Sharecare, Inc)|STRM (Streamline Health Solutions Inc.) - Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan syrahealth.com (SYRA)|Nilai perusahaan marang pendapatan AMEH|MODN: Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan NXGN (NextGen Healthcare)